Hims & Hers Health Inc has forecast 2026 revenue that will meet Wall Street's expectations, provided that it can continue selling copycat weight loss drugs that are mired in legal and regulatory risks ...
The popular weight loss drugs are both listed at more than $1,000 per month. The price cut is set for Jan. 1, 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results